Goldman Sachs’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
173,441
+73,661
| +74% | +$95.8K | ﹤0.01% | 4669 |
|
|
2025
Q1 | $139K | Buy |
99,780
+19,475
| +24% | +$27.1K | ﹤0.01% | 4757 |
|
|
2024
Q4 | $184K | Buy |
80,305
+27,416
| +52% | +$62.8K | ﹤0.01% | 4683 |
|
|
2024
Q3 | $144K | Buy |
52,889
+39,563
| +297% | +$108K | ﹤0.01% | 4556 |
|
|
2024
Q2 | $31.2K | Buy |
13,326
+993
| +8% | +$2.32K | ﹤0.01% | 4588 |
|
|
2024
Q1 | $57.8K | Buy |
12,333
+2,232
| +22% | +$10.5K | ﹤0.01% | 4523 |
|
|
2023
Q4 | $8.01M | Sell |
10,101
-8,848
| -47% | -$7.02M | ﹤0.01% | 2247 |
|
|
2023
Q3 | $261K | Buy |
+18,949
| New | +$261K | ﹤0.01% | 4168 |
|